We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Immunologic Function in the Elderly After Injury

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00447135
First Posted: March 14, 2007
Last Update Posted: January 30, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Summa Health System
  Purpose
The purpose of this research is to learn more about the function of the body's ability to fight infection when the immune response is activated when injury occurs, in the elderly population.

Condition
Over the Age of 65 Admitted to the Trauma Service

Study Type: Observational
Study Design: Time Perspective: Retrospective
Official Title: Immunologic Function in the Elderly After Injury: the Polymorphonuclear Leukocyte (PMN) and Innate Immunity

Further study details as provided by Summa Health System:

Enrollment: 55
Study Start Date: March 2005
Study Completion Date: December 2005
Primary Completion Date: December 2005 (Final data collection date for primary outcome measure)
  Show Detailed Description

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   66 Years and older   (Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Elderly after injury
Criteria

Inclusion Criteria:

  • Greater than 65
  • Admitted to the trauma service

Exclusion Criteria:

  • Inability to draw sufficient blood
  • Immunocompromised
  • Currently receiving systemic corticosteroids
  • Participation in other studies
  • In the opinion of the investigator will not be able to complete protocol
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00447135


Locations
United States, Ohio
Summa Health System
Akron, Ohio, United States, 44304
Sponsors and Collaborators
Summa Health System
Investigators
Principal Investigator: William Fallon, MD Summa Health System
  More Information

Responsible Party: Dr. William Fallon, Summa Health System
ClinicalTrials.gov Identifier: NCT00447135     History of Changes
Other Study ID Numbers: 04104
First Submitted: August 7, 2006
First Posted: March 14, 2007
Last Update Posted: January 30, 2008
Last Verified: January 2008

Keywords provided by Summa Health System:
Elderly
Trauma
Polymorphonuclear Leukocyte
Immunity